Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10636102 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors;   Resected Gastrointestinal Stromal Tumors;   Non-metastatic;   High Risk of Recurrence;   KIT Gene Mutation
Intervention: Drug: Imatinib maintenance
2 Completed Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)
Condition: GIST
Interventions: Drug: Pazopanib;   Other: Best supportive care

Study has passed its completion date and status has not been verified in more than two years.